US Patent Issued to Trustees of Tufts College on Nov. 25 for "Combination therapies using immuno-DASH inhibitors and PGE2 antagonists" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,609, issued on Nov. 25, was assigned to Trustees of Tufts College (Medford, Mass.).

"Combination therapies using immuno-DASH inhibitors and PGE2 antagonists" was invented by William W. Bachovchin (Cambridge, Mass.), Hung-sen Lai (Andover, Mass.) and Wengen Wu (Winchester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are combination therapies including administration of I-DASH inhibitors and PGE2 antagonists, and the use of such therapies in the treatment of cell proliferative diseases."

The patent was filed on Jan. 5, 2024, under Application No. 18/405,593.

*For further information, including images, charts and tables, please vis...